FOXO4-DRI

FOXO4-DRI is a synthetic peptide designed to selectively disrupt the interaction between FOXO4 and p53, thereby promoting the clearance of senescent cells and supporting tissue rejuvenation.

This compound functions by modulating key transcriptional pathways involved in cellular stress response and apoptosis, making it an innovative tool for studies focused on senescence, age-related tissue decline, and regenerative biology.

FOXO4-DRI plays a significant role in influencing cellular homeostasis by encouraging the removal of dysfunctional cells, thereby aiding in the restoration of healthy cellular networks. Research has indicated its potential to improve tissue repair, reduce pro-inflammatory signaling, and enhance resilience against age-associated degenerative processes.

Beyond its senolytic activity, FOXO4-DRI may contribute to improved mitochondrial function, better systemic balance, and the maintenance of youthful cellular environments.

FOXO4-DRI (15mg) offers a valuable compound for exploring therapeutic strategies related to longevity, tissue regeneration, and age-associated disease models, making it an important asset for advanced biomedical research.

FOXO4-DRI is provided in reconstituted vials or pre-pulled syringes for 3 times per week use for one month, and cycle off for one month. It is typically administered once per day subcutaneously in the abdomen, thigh, or upper arm. Dosage duration may vary based on individual needs and provider guidance. Store syringes in the refrigerator and follow all included instructions carefully. FOXO4-DRI starting dose is : 3 mg per injection. 

*All peptide sales are non‑refundable and non‑returnable. However, your satisfaction is important to us — if there is any problem with your order, please contact us right away and we will work with you to make it right.